Table 5.
Comparing CCI scores within subpopulation identified with HIV/AIDS by Deyo system | ||
Presence of AIDS according to CDMF ICD-9 system | CCI instrument | Mean CCI (95% CI) |
HIV infection without AIDS (N = 1049) | Deyo CCI | 11.10 (10.95-11.24) |
New CCI | 8.22 (8.07-8.37) | |
HIV infection with AIDS (N = 241) | Deyo CCI | 12.34 (11.97-12.70) |
New CCI | 12.76 (12.37-13.15) | |
Prevalence of diabetes within overall panel (N = 2,038,848) | ||
Subpopulation | CCI instrument | Patients with diabetes, % (95% CI) |
Diabetes | Deyo CCI | 32.25 (32.18-32.31) |
New CCI | 32.44 (32.38-32.50) | |
Mild-to-moderate | Deyo CCI | 19.17 (19.12-19.22) |
New CCI | 18.41 (18.35-18.46) | |
Severe | Deyo CCI | 13.08 (13.03-13.12) |
New CCI | 14.03 (13.99-14.08) | |
Comparison of CCI scores within subpopulation identified with renal disease by Deyo system | ||
Disease severity per CDMF ICD-9 system | CCI instrument | Mean CCI (95% CI) |
Mild/moderate renal disease (N = 337,119) | Deyo CCI | 7.70 (7.69-7.70) |
New CCI | 7.05 (7.05-7.06) | |
Severe renal disease (N = 44,703) | Deyo CCI | 8.51 (8.49-8.54) |
New CCI | 9.89 (9.87-9.91) |
CCI indicates Charlson Comorbidity Index; CI, confidence interval; ICD-9, International Classification of Diseases, Ninth Revision.